View Press Releases
-
Abzena invests $60m into cGMP manufacturing capacity
SAN DIEGO, CA, UNITED KINGDOM - Oct 8, 2020 - Leading contract provider of integrated discovery, development and manufacturing services for biologics and bioconjugates, Abzena, has invested $60m into a new facility for late phase and commercial cGMP manufacturing
Oct 8, 2020
-
Solentim to supply cell line development solutions for Samsung Biologics’ new R&D center in San Francisco
BOURNEMOUTH, UNITED KINGDOM - Oct 7, 2020 - Solentim is pleased to announce the adoption of its VIPS single cell seeding platform and Cell Metric® CLD into Samsung Biologics new research and development facility in San Francisco, CA
Oct 7, 2020
-
Sandia helps safeguard biological data threatened during COVID-19 pandemic
CAMBRIDGE, UNITED KINGDOM - Oct 6, 2020 - A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment has become more relevant after the United States and others issued warnings that hackers were using the COVID-19 pandemic to increase their activities
Oct 6, 2020
-
NVIDIA and PetaGene Combine Genomic Technologies to Address Critical Analysis Bottlenecks
CAMBRIDGE, UK - Oct 6, 2020 - PetaGene and NVIDIA announce seamless integration of PetaGene's PetaSuite tools as a standard part of NVIDIA Clara Parabricks Pipelinesx
Oct 6, 2020
-
TrialScope Adds Eisai to Its Community of Study Sponsors
JERSEY CITY, NJ, US - Oct 6, 2020 - TrialScope, the global leader in clinical trial disclosure and transparency management technology, has added a new study sponsor to its growing customer roster
Oct 6, 2020
-
InSysBio to release the new version of DBSolve Optimum
MOSCOW, RUSSIA - Oct 6, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, releases the new version of mathematical simulation workbench DBSolveOptimum 2020
Oct 6, 2020
-
Sterling Pharma Solutions launches £11 million Material Science Centre
- Sep 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has officially opened its new multi-million-pound Material Science Centre (MSC), after announcing the investment last year
Oct 6, 2020
-
Abzena appoints Giovanni Escobar as SVP and Site Head of Bristol, Pennsylvania Operations
CAMBRIDGE, UNITED KINGDOM - Oct 5, 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Giovanni Escobar as Senior Vice President (SVP) and Site Head of its Bristol Operations
Oct 5, 2020
-
VERICHEM LABORATORIES OFFERS LIQUID STABLE, READY-TO-USE, MULTI-ANALYTE ELECTROLYTE STANDARD KIT
PROVIDENCE, RI, UNITED STATES - Oct 5, 2020 - VERICHEM LABORATORIES is pleased to announce the availability of a ready-to-use, liquid stable Electrolyte Standard Kit
Oct 5, 2020
-
Panthera Biopartners concludes Series A financing with Gresham House Ventures as major investor
PRESTON, UNITED KINGDOM - Oct 2, 2020 - Panthera Biopartners (Panthera) has completed a Series A funding round with Gresham House Ventures as a major investor
Oct 2, 2020
-
A vulnerability in IBM Maximo asset management system, discovered by Positive Technologies, was fixed
FRAMINGHAM, MA, UNITED STATES - Oct 1, 2020 - Framingham, MA (October 1, 2020) -- A vulnerability in IBM Maximo Asset Management software was discovered by Positive Technologies experts Andrey Medov and Arseny Sharoglazov
Oct 1, 2020
-
OSF HealthCare Implements New Digital Solutions to Help Consumers Find the Right Care Online
BOSTON, MA, UNITED STATES - Oct 1, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that OSF HealthCare, a not-for-profit Catholic health system based in Illinois, is now connecting consumers with care through Kyruus ProviderMatch® for Consumers
Oct 1, 2020
-
AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence
ISSOIRE, FRANCE - Oct 1, 2020 - Belgium-based AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devices
Oct 1, 2020
-
Sterling Pharma Solutions acquires API facility in the US
GERMANTOWN, WI, US - Sep 30, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcamis Germantown, Wisconsin facility in the US
Sep 30, 2020
-
Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering
COVENTRY, UNITED KINGDOM - Sep 30, 2020 - NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck
Sep 30, 2020
-
Standigm and SK holdings C&C Release an AI-Based Target Identification Platform, iCLUE&ASK™, to Accelerate Drug Discovery Process
SEOUL, SOUTH KOREA - Sep 29, 2020 - Standigm Inc. (Standigm), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, Co
Sep 29, 2020
-
Jumpcode Genomics Exits Stealth Mode, Unveils Technology that Addresses the ‘Needle in the Haystack’ Problem of Molecular Biology
CARLSBAD, CA, UNITED STATES - Sep 17, 2020 - Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and announced the commercial launch of its CRISPRclean technology
Sep 17, 2020
-
Romain Madelaine, Ph.D., Joins MDI Biological Laboratory Faculty
BAR HARBOR, ME, UNITED STATES - Sep 17, 2020 - The MDI Biological Laboratory has announced that Romain Madelaine, Ph.D., has been appointed to the faculty as an assistant professor
Sep 17, 2020
-
Huntington Study Group Announces a Partnership with Prilenia Therapeutics to Conduct a Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease
ROCHESTER, NY, UNITED STATES - Sep 17, 2020 - The Huntington Study Group (HSG), a world leader in clinical research for Huntingtons Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R
Sep 17, 2020
-
ZEISS enhances efficiency in multi-scale and multi-modal workflows
JENA, GERMANY - Sep 2, 2020 - Materials and Life Science researchers can now experience faster accessibility of deeper regions of interest when investigating samples in 3D
Sep 16, 2020